Establishment Labs
ESTA | NASDAQ
$69.82
-$0.93 (-1.31%)
At close: Nov 16, 2026, 4:00 PM ET
$69.82
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
Establishment Labs Company Profile
Company profile explainedCompany Profile
Establishment Labs Holdings Inc. operates as a medical technology enterprise specializing in the creation and commercialization of devices for aesthetic and reconstructive plastic surgery. The company is primarily recognized for its silicone gel-filled breast implants, sold under the Motiva Implants brand. Among these are the Motiva Ergonomix and Motiva Ergonomix2, which are distinctive, gravity-sensitive, round, soft silicone-gel-filled implants. Furthermore, Establishment Labs provides the Motiva Flora Tissue Expander for breast tissue and distributes the Puregraft range of products, utilized for the harvesting and redistribution of autologous adipose tissue. The firm markets its offerings across Europe, Latin America, the Asia-Pacific region, and other global markets, leveraging both a direct sales force and exclusive distributors. Founded in 2004, Establishment Labs has its main office situated in Alajuela, Costa Rica.
Key Executives
| Name | Position |
|---|---|
| Fillipo Peter Caldini | Chief Executive Officer & Director |
| Roberto de Mezerville | Chief Technology Officer |
| Cassandra E. Harris | Senior VP & CFO |
| Ivan Bilic | Senior Vice President of Commercial Operations - OUS |
| Jeff Ehrhard | Senior Vice President & GM of North America |
| Malavika William | VP, Global Head of Marketing & Communications |
| S. Ross Mansbach | General Counsel, Chief Compliance Officer & Chief Human Resources Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 29, 2026 | 8-K | Current Report |
| Oct 15, 2026 | 8-K | Current Report |
| Oct 02, 2026 | 4 | Filing |
| Oct 02, 2026 | 4 | Filing |
| Oct 02, 2026 | 4 | Filing |
| Oct 02, 2026 | 4 | Filing |
| Oct 02, 2026 | 4 | Filing |
| Aug 26, 2026 | 4 | Filing |
| Aug 07, 2026 | 10-Q | Quarterly Report |
| Aug 06, 2026 | 8-K | Current Report |
Establishment Labs
| Country | United States |
| IPO Date | Jul 19, 2018 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 1,004 |
| CEO | Fillipo Peter Caldini |
Contact Details
11401 century oaks terrace Austin,
Texas 78758 United States
Stock Details
| Ticker Symbol | ESTA |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001688757 |
| CUSIP Number | G31249108 |
| ISIN Number | VGG312491084 |
| SIC Code | 3842 |
Recent News
- 19 days ago / seekingalpha.comEstablishment Labs Holdings Inc. (ESTA) Q3 2026 Earnings Call Transcript
- 19 days ago / zacks.comEstablishment Labs Holdings Inc. (ESTA) Reports Q3 Loss, Beats Revenue Estimates
- 19 days ago / marketbeat.comWhat Establishment Labs (ESTA) Said on Its Q3 Earnings Call
- 26 days ago / zacks.comEstablishment Labs Holdings Inc. (ESTA) Expected to Beat Earnings Estimates: Should You Buy?
- 29 days ago / businesswire.comEstablishment Labs® to Announce Third Quarter 2026 Financial Results on October 29
- 2 months ago / businesswire.comEstablishment Labs® Highlights New Breast Tissue Preservation Data and Announces Minimally Invasive Product Extensions at the 11th World Symposium on Ergonomic Implants
- 2 months ago / seekingalpha.comEstablishment Labs: Procedure Economics Strengthens The Bull Case
- 3 months ago / seekingalpha.comEstablishment Labs Holdings Inc. (ESTA) Q2 2026 Earnings Call Transcript
- 3 months ago / marketbeat.comEstablishment Labs Q2 Earnings Call Highlights
- 3 months ago / zacks.comEstablishment Labs Holdings Inc. (ESTA) Reports Q2 Loss, Tops Revenue Estimates
Add to Watchlist
Select watchlists to add or remove ESTA